BioRem Inc. (TSXV:BRM)
Canada · Delayed Price · Currency is CAD 3.620
-0.020 (-0.55%)
Aug 28, 2026, 3:59 PM EST
BioRem Financials Overview
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 50.7 | 42.36 | 37.42 | 25.17 | 28.86 | 24.48 |
Revenue Growth | 32.16% | 13.19% | 48.69% | -12.81% | 17.91% | 0.42% |
Gross Profit Gross Profit Growth | 15.41 | 12.77 | 10.06 | 7.02 | 8.76 | 6.24 |
Operating Income Operating Income Growth | 8.32 | 6.57 | 4.39 | 3.09 | 2.88 | 2.33 |
Net Income Net Income Growth | 6.22 | 4.82 | 3.04 | 2.18 | 1.61 | 1.3 |
Earnings Per Share EPS Growth | 0.34 | 0.26 | 0.16 | 0.13 | 0.09 | 0.04 |
EPS Growth | 107.15% | 62.50% | 23.08% | 44.45% | 149.20% | -27.77% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Standard Products and Services Standard Products and Services Growth | - | 2.01 | 1.61 | 1.44 | 1.56 | 2.56 |
Construction Contracts Construction Contracts Growth | - | 40.34 | 35.81 | 23.73 | 27.3 | 21.92 |
Revenue (Total) Revenue (Total) Growth | 50.7 | 42.36 | 37.42 | 25.17 | 28.86 | 24.48 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7.19 | 11.5 | 5.21 | 2.29 | 3.78 | 4.47 |
Total Debt Total Debt Growth | 2.49 | 2.83 | 3.56 | 4.19 | 4.75 | 5.67 |
Net Cash (Debt) Net Cash Growth | 4.69 | 8.67 | 1.66 | -1.89 | -0.97 | -1.19 |
Net Cash Growth | 3.98% | 423.68% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.25 | 0.47 | 0.09 | -0.12 | -0.06 | -0.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 0.33 | 7.64 | 3.69 | 0.49 | 1.44 | 3.78 |
Capital Expenditures CapEx Growth | -0.32 | -0.37 | -0.37 | -0.55 | -0.2 | -0.08 |
Free Cash Flow Free Cash Flow Growth | 0.01 | 7.27 | 3.31 | -0.06 | 1.24 | 3.71 |
Free Cash Flow Growth | -99.78% | 119.45% | - | - | -66.50% | 23.48% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 30.40% | 30.14% | 26.87% | 27.90% | 30.36% | 25.48% |
Operating Margin | 16.41% | 15.52% | 11.74% | 12.26% | 9.97% | 9.54% |
Pretax Margin | 16.24% | 14.94% | 11.09% | 11.08% | 8.26% | 8.31% |
Profit Margin | 12.26% | 11.37% | 8.13% | 8.66% | 5.59% | 5.30% |
FCF Margin | 0.02% | 17.17% | 8.85% | -0.25% | 4.30% | 15.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.76 | 9.04 | 16.15 | 7.20 | 8.46 | 10.74 |
Forward PE | 9.40 | 10.39 | - | - | - | - |
P/FCF Ratio | 6064.63 | 5.99 | 14.84 | - | 10.98 | 3.76 |
PS Ratio | 1.16 | 1.03 | 1.31 | 0.62 | 0.47 | 0.57 |